Keywords: -vivus, muse, alprostadil, approved, france, vivus, been
-Vivus' MUSE (alprostadil) approved in France
Article | 29 March 1999
- Vivus' MUSE (alprostadil) has been approved in France for thetreatment of erectile dysfunction. The approval triggered a $2 million milestone payment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
